Mabtas 500 Infusion

 115 people have bought this recently
50 ml Infusion in 1 Bottle Out of Stock
₹ 41567.12
50 ML INFUSION 1 Bottle ₹ 41567.12
  • Out of Stock

Mabtas 500 Infusion

50 ml Infusion in 1 Bottle
₹ 41567
50 ML INFUSION | 1 Bottle
₹ 41567
115 people have bought this recently

Mabtas Information

Mabtas is a prescription drug, available for use as Injection, Infusion. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Secondary and off-label uses of Mabtas have also been mentioned below.

The optimal dosage of Mabtas is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.

Mabtas also has some side effects, the most common being Weakness. Apart from the aforementioned side effects, Mabtas can also lead to other problems, which have been listed below. These side effects of Mabtas are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.

Mabtas's effect during pregnancy is Moderate and Severe while nursing. Warnings related to Mabtas's effects on the liver, heart and kidney, if any, have been listed below.

Mabtas can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mabtas in conditions like Hyperkalemia. Other conditions have been mentioned below in the Mabtas contraindications section.

Drug interactions for Mabtas have been reported in the medical literature. A complete list of these interactions is given below.

In addition to these precautions, you may also note that Mabtas is not safe while driving, and is is not addictive in nature.



Mabtas Benefits & Uses

Mabtas is used to treat the following -

Other Benefits

Mabtas Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group Dosage
Adult
  • Disease: Non-Hodgkin Lymphoma
  • Before or After Meal: As advised by a physician
  • Single Maximum Dose: 600 mg
  • Dosage Route: Parenteral
  • Frequency: doctor administered
  • Course Duration: As directed by the doctor
  • Special Instructions: As prescribed by the doctor
Geriatric
  • Disease: Non-Hodgkin Lymphoma
  • Before or After Meal: As advised by a physician
  • Single Maximum Dose: 600 mg
  • Dosage Route: Parenteral
  • Frequency: doctor administered
  • Course Duration: As directed by the doctor
  • Special Instructions: As prescribed by the doctor

Mabtas Related Warnings

  • Is the use of Mabtas safe for pregnant women?


    Mabtas can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Mabtas right away. Take your doctor's advice before taking it again.

    Moderate
  • Is the use of Mabtas safe during breastfeeding?


    Women who are breastfeeding, may experience serious side effects after taking Mabtas. So it is adviced to consult the doctor before using it.

    Severe
  • What is the effect of Mabtas on the Kidneys?


    There can be some harmful effects on your kidneys after taking Mabtas. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.

    Moderate
  • What is the effect of Mabtas on the Liver?


    Mabtas does not damage the liver.

    Safe
  • What is the effect of Mabtas on the Heart?


    There may be an adverse effect on the heart after taking Mabtas. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.

    Moderate


Severe Interaction of Mabtas with Other Drugs

Mabtas should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Moderate



Mabtas Contraindications

If you are suffering from any of the following diseases, you should not take Mabtas unless your doctor advises you to do so -



Frequently asked Questions about Mabtas

  • Is this Mabtas habit forming or addictive?


    No, you will not get addicted to Mabtas.

    No
  • Is it safe to drive or operate heavy machinery when consuming?


    No, you should not drive or operate heavy machinery after taking Mabtas as you may feel sleepy.

    Dangerous
  • Is it safe?


    Yes, but take Mabtas only as per medical advice.

    Safe, but take only on Doctor's advise
  • Is it able to treat mental disorders?


    No, the use of Mabtas in mental disorders is not effective.

    No

Mabtas Interactions with Food and Alcohol

  • Interaction between Food and Mabtas


    You can take Mabtas with food.

    Safe
  • Interaction between Alcohol and Mabtas


    No research has been done on this till date. Therefore, it is not known what the effect of taking Mabtas with alcohol will be.

    Unknown


See all substitutes for Mabtas


This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience


References

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872



In stock alternatives of Mabtas (based on Rituximab (500 mg))

Reditux 500 Injection 50 Ml
Reditux 500 Injection 50 Ml 50 ml Injection in 1 Packet ₹37675
Enfiera Injection 500 mg
Enfiera Injection 500 mg 1 Injection in 1 Packet ₹28351 ₹4050230% off
Lupiximab Injection
Lupiximab Injection 1 Injection in 1 Packet ₹8500
Cytomab 500 Injection
Cytomab 500 Injection 1 ml Injection in 1 Packet ₹38541


See Similar Category Medicines Here




BEST ALTERNATIVE
₹719 ₹799 10% OFF
Joint Capsule